✦ LIBER ✦

Benzothienyloxy Phenylpropanamines, Novel Dual Inhibitors of Serotonin and Norepinephrine Reuptake.

✍ Scribed by P. T. Gallagher; et al. et al.

Publisher: John Wiley and Sons
Year: 2005
Weight: 16 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200508105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Structure—Activity Relatio

Discovery and Structure—Activity Relationships of Novel Selective Norepinephrine and Dual Serotonin/Norepinephrine Reuptake Inhibitors.

✍ Magnus W. Walter; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Duloxetine (Cymbalta), a Dual Inhibitor

Duloxetine (Cymbalta), a Dual Inhibitor of Serotonin and Norepinephrine Reuptake.

✍ F. P. Bymaster; E. E. Beedle; J. Findlay; P. T. Gallagher; J. H. Krushinski; S. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 113 KB 👁 1 views

N-Alkyl-N-arylmethylpiperidin-4-amines:

N-Alkyl-N-arylmethylpiperidin-4-amines: Novel Dual Inhibitors of Serotonin and Norepinephrine Reuptake.

✍ P. T. Gallagher; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 14 KB 👁 1 views

More than one-half of a decade of experi

More than one-half of a decade of experience with venlafaxine dual serotonin-norepinephrine reuptake inhibitor

✍ Charles B. Nemeroff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

ChemInform Abstract: Thiophene Derivativ

ChemInform Abstract: Thiophene Derivatives: A New Series of Potent Norepinephrine and Serotonin Reuptake Inhibitors.

✍ Ao Zhang; Guochun Zhou; Suo-Bao Rong; Kenneth M. Johnson; Mei Zhang; Alan P. Koz 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

Serotonin norepinephrine reuptake inhibi

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy

✍ Bernardo Dell'Osso; Massimiliano Buoli; David S. Baldwin; A. Carlo Altamura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract Anxiety disorders are common psychiatric conditions that typically require long‐term treatment. This review summarizes current knowledge of the pharmacological treatment of anxiety disorders with serotonin norepinephrine reuptake inhibitors (SNRIs) with specific emphasis on the findings